141 related articles for article (PubMed ID: 6966495)
1. Immune thrombocytopenia induced by cotrimoxazole.
Barr AL; Whineray M
Aust N Z J Med; 1980 Feb; 10(1):54-5. PubMed ID: 6966495
[TBL] [Abstract][Full Text] [Related]
2. Metabolite-specific (IgG) and drug-specific antibodies (IgG, IgM) in two cases of trimethoprim-sulfamethoxazole-induced immune thrombocytopenia.
Kiefel V; Santoso S; Schmidt S; Salama A; Mueller-Eckhardt C
Transfusion; 1987; 27(3):262-5. PubMed ID: 3296342
[TBL] [Abstract][Full Text] [Related]
3. [Acute cotrimoxazole-induced thrombocytopenia, facilitating role of phenobarbital (author's transl)].
Thorel JB; Daragon A; Manchon N; Courtois H
Sem Hop; 1981 May 8-15; 57(17-18):914-5. PubMed ID: 6262932
[TBL] [Abstract][Full Text] [Related]
4. Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients.
Jick H
Rev Infect Dis; 1982; 4(2):426-8. PubMed ID: 6981160
[TBL] [Abstract][Full Text] [Related]
5. Severe thrombocytopenia-hemorrhage due to trimethoprim-sulfamethoxazole: a case report.
Ahmad S
W V Med J; 1984 Oct; 80(10):219-20. PubMed ID: 6388160
[No Abstract] [Full Text] [Related]
6. Prophylactic use of TMP-SMZ in leukemia.
Lanzkowsky P; Schaeffer J
J Pediatr; 1982 Jun; 100(6):1002-3. PubMed ID: 6979621
[No Abstract] [Full Text] [Related]
7. [Thrombocytopenia during treatment with sulphamethoxazole with trimethoprim].
Nielsen HV
Ugeskr Laeger; 1980 Feb; 142(7):451-2. PubMed ID: 7368396
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulphamethoxazole and thrombocytopenia.
Dickson HG
Med J Aust; 1978 Jul; 2(1):5-7. PubMed ID: 683114
[TBL] [Abstract][Full Text] [Related]
9. Letter: Thrombocytopenia with combined trimethoprim-sulphamethoxazole and allopurinol therapy.
Raik E; Vincent PC
Med J Aust; 1973 Sep; 2(9):468. PubMed ID: 4748575
[No Abstract] [Full Text] [Related]
10. Hematological side effects of co-trimoxazole.
Heimpel H; Raghavachar A
Infection; 1987; 15 Suppl 5():S248-53. PubMed ID: 3325435
[TBL] [Abstract][Full Text] [Related]
11. Cotrimoxazole reaction simulating sepsis.
Shalit M; Levy M
J Infect; 1984 Nov; 9(3):291-2. PubMed ID: 6335518
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia secondary to trimethoprim-sulfamethoxazole.
Hagen MD; White RD
South Med J; 1983 Apr; 76(4):503. PubMed ID: 6836368
[TBL] [Abstract][Full Text] [Related]
13. IgM platelet autoantibody due to sodium valproate.
Sandler RM; Emberson C; Roberts GE; Voak D; Darnborough J; Heeley AF
Br Med J; 1978 Dec; 2(6153):1683-4. PubMed ID: 367512
[No Abstract] [Full Text] [Related]
14. Myelosuppression complicating cotrimoxazole prophylaxis after bone marrow transplantation.
Schey SA; Kay HE
Br J Haematol; 1984 Jan; 56(1):179-80. PubMed ID: 6367807
[No Abstract] [Full Text] [Related]
15. Thrombocytopenia associated with PF3 antiplatelet activity against the sulfa component of trimethoprim-sulfamethoxazole.
Schwartz RH; Rodriguez WJ; Luban NL
South Med J; 1981 May; 74(5):640-1. PubMed ID: 7244730
[TBL] [Abstract][Full Text] [Related]
16. Adverse haematological effects and trimethoprim-sulphamethoxazole administration.
Casey TP; Matthews JR; Buchanan JG
N Z Med J; 1973 Nov; 78(503):433-5. PubMed ID: 4521500
[No Abstract] [Full Text] [Related]
17. Early and late neutropenia in children treated with cotrimoxazole (trimethoprim-sulfamethoxazole).
Principi N; Marchisio P; Biasini A; Dalla Villa A; Biasini G
Acta Paediatr Scand; 1984 Nov; 73(6):763-7. PubMed ID: 6335347
[TBL] [Abstract][Full Text] [Related]
18. Serum trimethoprim and sulphamethoxazole levels in AIDS.
Bowden FJ; Harman PJ; Lucas CR
Lancet; 1986 Apr; 1(8485):853. PubMed ID: 2870332
[No Abstract] [Full Text] [Related]
19. [Cotrimoxazole-induced agranulocytosis].
Med Clin (Barc); 1988 May; 90(18):755. PubMed ID: 3262795
[No Abstract] [Full Text] [Related]
20. Immunological effect of co-trimoxazole on platelets.
Claas FH; van der Meer JW; Langerak J
Br Med J; 1979 Oct; 2(6195):898-9. PubMed ID: 391322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
